ADDITIONAL INFO

226MG Sleep Mix — Circadian & Neurotransmitter Research Formulation

226MG Sleep Mix is a targeted research formulation designed for studies of circadian rhythm regulation, neurotransmitter signaling, and neuromodulatory mechanisms. Each 226 mg dose contains GABA (100 mg), L-Arginine (100 mg), Melatonin (1 mg), and L-Glutamine (25 mg). This combination is commonly used in in vitro research to investigate sleep–wake cycle modulation, nitric oxide production, and neurotransmitter balance. GABA and Melatonin are particularly studied for their roles in neuronal excitability and circadian signaling, while L-Arginine and L-Glutamine support research into metabolic pathways and cellular repair.

For in‑vitro laboratory research only. Not a drug, food, cosmetic, or veterinary product. Not for human or animal administration.

Product Details
Compound Name: 226MG Sleep Mix
Active Components: GABA (100 mg), L-Arginine (100 mg), Melatonin (1 mg), L-Glutamine (25 mg)
Net Contents: 20 mL
Form: Laboratory-grade powder or buffered solution
Purity: ≥98% (component-level testing; Certificate of Analysis available)
Primary Targets: Circadian rhythm pathways, neurotransmitter signaling, nitric oxide production, neuronal excitability
Manufactured in: GMP-compliant facility
Intended Use: Laboratory research use only — not for human or veterinary use

Storage & Handling

• Store sealed at 2–8 °C, protected from light and moisture

• Allow vial to reach room temperature before opening

• Reconstitute under sterile conditions if supplied as powder

• Avoid repeated freeze–thaw cycles

• Maintain sterile technique during handling

• Consult SDS for safety and handling guidance

Research Applications

• Circadian rhythm and sleep–wake cycle studies

• Neurotransmitter signaling and neuronal excitability investigations

• Nitric oxide pathway and metabolic research

• Cellular repair and neuroprotective mechanisms

• In vitro models of neuromodulatory processes